Spectrum Asset Management (California)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-13,549
Closed -$704K 85
2018
Q4
$704K Sell
13,549
-1
-0% -$54 0.56% 54
2018
Q3
$841K Buy
+13,550
New +$804K 0.5% 63

Other funds holding BMY

Spectrum Asset Management (California)'s BMY Position: Q1 2019 in Review

Spectrum Asset Management (California) sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 13,549 shares — an estimated $704K sold.

Spectrum Asset Management (California) first reported a position in BMY in Q3 2018 and held it in 2 quarters. The position peaked at $841K in Q3 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Spectrum Asset Management (California) reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Spectrum Asset Management (California) sold 13,549 Bristol-Myers Squibb shares in Q1 2019, an estimated $704K.
  • Spectrum Asset Management (California) first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 2 quarters.
  • Spectrum Asset Management (California)'s Bristol-Myers Squibb position peaked at $841K in Q3 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Spectrum Asset Management (California)'s 13F filing for Q1 2019, filed 16 Apr 2019.